# Annovis Bio Receives NYSE Noncompliance Notice Over Listing Shortfalls

By Riza Dagoc

Canonical URL: https://www.tokenpost.com/news/regulation/45183
Published: 2026-10-30T22:23:54.000Z
Updated: 2026-10-30T22:23:54.000Z
Section: Regulation

> The notice cited a 30-trading-day average market capitalization of about $48.4 million and a stockholders’ deficit of about $4.3 million.

Annovis Bio, Inc. (NYSE: ANVS) received a noncompliance notice from the New York Stock Exchange on Oct. 29 after falling short of continued-listing standards for market capitalization and stockholders’ equity.

The company’s average market capitalization over 30 trading days was about $48.4 million as of Oct. 28. Its stockholders’ deficit was about $4.3 million as of June 30.